Apimeds Pharmaceuticals US Inc
Research Apimeds Pharmaceuticals US Inc (APUS) on Bullrun: market cap USD 7.58M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAPUS
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 7.58M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 20.17M
- Free cash flow-USD 5.67M
Valuation Snapshot
latest market cap is USD 7.58M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 6.00M | -USD 8.98M | n/a | -0.55 | USD 1.64M | USD 7.76M | USD 153.35M |
| FY2024 | USD 0 | -USD 1.39M | -USD 733.53K | n/a | -0.18 | USD 3.46K | USD 596.84K | -USD 1.36M |
| FY2023 | USD 0 | -USD 777.69K | -USD 627.79K | n/a | -0.17 | USD 410.48K | USD 266.89K | USD 31.87K |
| FY2022 | USD 0 | -USD 668.67K | -USD 448.17K | n/a | -0.58 | USD 6.17K | USD 660.00K | -USD 713.61K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 7.58M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 206.25M | n/a | n/a | n/a |
About Apimeds Pharmaceuticals US Inc
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Apimeds Pharmaceuticals US Inc's market cap?
Apimeds Pharmaceuticals US Inc's market capitalization is USD 7.58M.
What does Apimeds Pharmaceuticals US Inc do?
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.